Skip to content
Homepage
Author:
Amlogenyx Inc
Posted Date:
May 13, 2026
Amlogenyx Presents Preclinical Data on AM805, a Potentially Transformative Investigational Gene Therapy for Alzheimer’s Disease
Amlogenyx Inc
May 13, 2026
Amlogenyx Announces Positive Preclinical Data on AM805, a Potent Amyloid-Degrading Protease for the Treatment of Alzheimer’s Disease
Amlogenyx Inc
March 16, 2026
